Fundamentals data is not available for this company.
| Novartis wields the axe but revenues rise | 25-Oct-2011 | ShareCast |
| Pfizer Acquires Rights to Treatment for Rare Dis... | 02-Dec-2009 | New York Times |
| Tech Ticker | 10-Oct-2009 | BayArea.com |
| Amgen Cites Benefits of Osteoporosis Drug | 08-Jul-2009 | New York Times |
| Currency | US Dollars |
| Share Price | $ 51.96 |
| Change Today | $ 0.23 |
| % Change | 0.44 % |
| 52 Week High | $64.52 |
| 52 Week Low | $51.58 |
| Volume | 889,399 |
| Shares Issued | 353.16m |
| Market Cap | $18,350m |
| Beta | 0.66 |
| RiskGrade | 71 |
| Time | Volume / Share Price |
| 16:16 | 34,084 @ $51.96 |
| 16:15 | 100 @ $51.99 |
| 16:15 | 100 @ $51.99 |
| 16:15 | 200 @ $51.98 |
| 16:15 | 200 @ $51.98 |
You are here: research